# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elisabeth of Austria (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI030-SYN
- Date: 2026-03-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Adelheid Marchetti-Osei, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week review of anorexia nervosa: weight, vital signs, electrolytes, bone density and depression. **S**

## History of present illness

Empress Elisabeth returns three weeks after her consultation. She has had four CBT-E sessions, two in person and two by video, has seen the dietitian twice, and had a video review with Dr. Haddad-Lindström last week; her plan is now about 2,200 kcal a day. She took the phosphorus tablets for three weeks and finished thiamine. The weekly blood tests were drawn at laboratories where she stayed and were reported to the clinic as normal. She has walked about an hour a day and stopped weighing herself at home, which she found very hard. The dizziness on standing has nearly gone and the ankle swelling is less. Her mood is still low and she thinks often of her son; she has had passive thoughts of death on two days, with no intent or plan. **S**

| Element | Detail |
|---|---|
| Treatment | Four CBT-E sessions; dietitian twice; about 2,200 kcal a day |
| Blood tests | Weekly tests drawn where she stayed; normal |
| Exercise | About an hour of walking a day |
| Symptoms | Dizziness nearly gone; ankle swelling less |
| Safety | Passive thoughts on two days; no intent or plan |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Energy a little better; still cold |
| Cardiovascular | Negative | No palpitations; ankle swelling less |
| Gastrointestinal | Positive | Fullness after meals, easing |
| Musculoskeletal | Negative | No bone pain or fractures |
| Psychiatric | Positive | Low mood and grief; PHQ-9 14 |

5 systems reviewed. **S**

## Current medications

- Cholecalciferol 50 microgram (2,000 IU) capsule, one by mouth daily **S**
- Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal **S**
- Sertraline 25 mg tablet, one by mouth each morning for two weeks **S**

## Allergies

- No known allergy **S**

## Objective

BP 100/64 mmHg; pulse 56 bpm; respirations 14/min; temperature 36.2 °C; oxygen saturation 98% on room air; weight 49.6 kg; BMI 16.8 kg/m². All vital signs are synthetic.

Hemoglobin: 11.9 g/dL (low); White cell count: 3.9 10*3/uL (low); Sodium: 138 mmol/L; Potassium: 3.9 mmol/L; Glucose: 80 mg/dL; Magnesium: 1.9 mg/dL; Phosphate: 3.2 mg/dL; ALT: 38 U/L (high); QTc: 436 ms; Lumbar spine T-score: -2.1 (low); Femoral neck T-score: -1.8 (low); FRAX major osteoporotic fracture: 6.8%; FRAX hip fracture: 1.2%; PHQ-9: 14. All results are synthetic.

## Change since baseline

- Hemoglobin: 11.2 g/dL (low) at baseline, 11.9 g/dL (low) at this visit **S**
- White cell count: 3.4 10*3/uL (low) at baseline, 3.9 10*3/uL (low) at this visit **S**
- Sodium: 136 mmol/L at baseline, 138 mmol/L at this visit **S**
- Potassium: 3.6 mmol/L at baseline, 3.9 mmol/L at this visit **S**
- Glucose: 68 mg/dL (low) at baseline, 80 mg/dL at this visit **S**
- Magnesium: 1.8 mg/dL at baseline, 1.9 mg/dL at this visit **S**
- Phosphate: 3 mg/dL at baseline, 3.2 mg/dL at this visit **S**
- ALT: 52 U/L (high) at baseline, 38 U/L (high) at this visit **S**
- QTc: 438 ms at baseline, 436 ms at this visit **S**
- PHQ-9: 16 at baseline, 14 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Thin; weight 49.6 kg, BMI 16.8; temperature 36.2 C |
| Cardiovascular | Lying blood pressure 102/66, pulse 54; standing 98/64, pulse 64; regular rhythm; trace ankle edema |
| Musculoskeletal | Standing height 172 cm; no spinal tenderness |
| Psychiatric | Mood low, affect constricted, tearful when speaking of her son; no intent or plan to harm herself |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Anorexia nervosa, restricting type, moderate, improving** (F50.011). Weight up 2.2 kg in four weeks, to BMI 16.8. Medically stable: pulse 56 seated, orthostatic rise now 10, potassium 3.9 mmol/L, phosphate 3.2 mg/dL, magnesium 1.9 mg/dL, glucose 80 mg/dL. Hemoglobin 11.9 g/dL and white cells 3.9 x10^3/uL are improving; ALT 38 U/L is falling. ECG: sinus rhythm 56, QTc 436 ms. **S**
   - Stop phosphorus tablets.
   - Continue the meal plan, CBT-E and the dietitian.
   - Electrolytes, phosphate and magnesium at each visit while underweight.
   - Walks of up to an hour a day; no gymnastics yet.
2. **Low bone mass after decades of low weight** (M85.80). DXA today: lumbar spine T-score -2.1, femoral neck -1.8, low bone mass. FRAX 10-year probabilities 6.8% for a major osteoporotic fracture and 1.2% for hip fracture, below the thresholds for drug treatment. Weight restoration is the main treatment. **S**
   - Calcium carbonate 1,250 mg daily with a meal, with dairy foods, for about 1,200 mg of calcium a day.
   - Continue vitamin D 2,000 IU daily; recheck 25-hydroxyvitamin D in about three months.
   - Repeat DXA in two years.
3. **Recurrent depression with persistent grief** (F33.1). PHQ-9 14, little changed. Nutrition is under way and the QTc is normal, so an antidepressant can start, as the consultant advised. Sertraline is chosen for its low QT risk and few interactions. **S**
   - Sertraline 25 mg each morning for two weeks, then 50 mg.
   - Nurse telephone check two weeks after starting.
   - Grief-focused work in CBT-E sessions.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline, the clinic number and local emergency numbers abroad confirmed.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Weight and BMI (open weighing in the consulting room) | Weekly at first, then every visit | Completed today | 49.6 kg, BMI 16.8; up 2.2 kg since intake; weekly weights at CBT-E sessions |
| Examination | Orthostatic pulse and blood pressure, and temperature | Every visit | Completed today | Pulse 54 lying, 64 standing; blood pressure 102/66 lying, 98/64 standing; temperature 36.2 C; orthostatic changes resolved |
| Laboratory | Sodium, potassium, phosphate, magnesium and glucose | Baseline; three to four days after nutrition starts; weekly for the first weeks; then at each visit while underweight | Completed today | Weekly tests normal; today sodium 138, potassium 3.9 mmol/L, phosphate 3.2 mg/dL, magnesium 1.9 mg/dL, glucose 80 mg/dL |
| Laboratory | Blood count and liver enzymes | Baseline; repeat when abnormal | Completed today | Hemoglobin 11.9 g/dL, white cells 3.9 x10^3/uL, ALT 38 U/L, all improving |
| Imaging | ECG for bradycardia and QTc | Baseline; repeat with abnormal electrolytes and before QT-prolonging drugs | Completed today | Sinus rhythm 56, QTc 436 ms, before sertraline |
| Imaging | DXA of the spine and hip | Once for a postmenopausal woman with long-standing low weight; then every two years | Completed today | Lumbar spine T-score -2.1, femoral neck -1.8 |
| Survey | FRAX 10-year fracture probability | With each DXA and when risk factors change | Completed today | 6.8% major osteoporotic, 1.2% hip |
| Self-management | Calcium and vitamin D intake | Every visit | Completed today | Calcium supplement started; vitamin D continued |
| Examination | Refeeding edema and signs of heart failure | Every visit | Completed today | Trace ankle edema |
| Self-management | Exercise and compulsive activity | Every visit | Completed today | About an hour of walking a day; no gymnastics |
| Self-management | Multidisciplinary treatment: CBT-E attendance, dietitian, psychiatry | Weekly therapy; dietitian every two weeks | Completed today | Four CBT-E sessions and two dietitian visits attended |
| Survey | PHQ-9 | At least monthly during acute treatment | Completed today | 14, from 16 |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | Passive thoughts of death on two days; no intent, plan or preparatory behavior; PHQ-9 item 9 scored 1. Safety plan reviewed |
| Medication safety | SSRI tolerability check two weeks after starting | 2 weeks after starting and after each dose change | Ordered | Nurse telephone check booked for two weeks from today |

## Goal progress

- Medically stable for outpatient care: resting pulse 50 or more, no orthostatic dizziness, and normal potassium, phosphate, magnesium and glucose. Outcome by 2026-03-03: Pulse 56, orthostatic changes resolved, electrolytes and glucose normal at four weeks. **S**
- Weight gain of about 0.5 to 1 kg a week toward a body mass index of at least 18.5. In progress; target 2026-08-31. **S**
- Depression response (PHQ-9 down by at least 50 percent) by six months. In progress; target 2026-06-30. **S**
- Exercise reduced to walks of an hour or less a day while weight is restored, with no gymnastics until the team agrees. In progress; target 2026-04-28. **S**

## Medication changes

- Stopped: Phosphorus 250 mg tablet (potassium and sodium phosphates), one by mouth twice daily with meals for three weeks **S**
- Started: Calcium carbonate 1,250 mg (500 mg elemental calcium) tablet, one by mouth daily with a meal **S**
- Started: Sertraline 25 mg tablet, one by mouth each morning for two weeks **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023), American Psychiatric Association (American Journal of Psychiatry 2023;180(2):167-171)
- Eating Disorders: A Guide to Medical Care (AED Medical Care Standards Guide), 4th edition (2021), Academy for Eating Disorders
- ASPEN Consensus Recommendations for Refeeding Syndrome (2020), American Society for Parenteral and Enteral Nutrition (Nutr Clin Pract 2020;35(2):178-195)
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders and osteoporosis monographs (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- Osteoporosis to Prevent Fractures: Screening (2025), U.S. Preventive Services Task Force

## Follow-up

- Nurse telephone check in two weeks. Preventive visit in three weeks. Review in eight weeks. **S**
- Next scheduled visit 2026-03-24: periodic adult preventive visit. **S**
